Relief Therapeutics Holding SA / Key word(s): Patent Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate 03-Oct-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to .
Relief Therapeutics Holding SA / Key word(s): Patent Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate
Relief Therapeutics Holding SA / Key word(s): Patent03-Oct-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Cove.
Relief Therapeutics Holding SA / Key word(s): Miscellaneous24-Aug-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.RELIEF THERAPEUTICS FILES REGISTRATION STATEMENT ON FORM F-1 WITH THE U.S. SECURITIES AND EXCHANGE COMMI.
Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics files registration statement on form F-1 with the U.S. Securities and Exchange Commission 24-Aug-2022 / 07:00 CET/CEST Release